Sunmax Biotechnology Co

Sunmax Biotechnology Co Enterprise Value

The Enterprise Value (EV) of Sunmax Biotechnology Co (4728.TWO) as of Nov 17, 2026 is 21.19 B TWD. In the previous year, Enterprise Value (EV) was 21.19 B TWD — a change of 0.00% (lower).

Enterprise Value

21.19 BTWD

YoY

0.00%

Last updated:

Enterprise Value (EV) of Sunmax Biotechnology Co is 2025 21.19 B TWD. Enterprise Value (EV) of Sunmax Biotechnology Co was 2024 21.19 B TWD. It decreases by 0.00% lower compared to the previous year.

The Sunmax Biotechnology Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
21.21 B TWD
Jan 1, 2019
21.19 B TWD
Jan 1, 2020
20.41 B TWD
Jan 1, 2021
20.62 B TWD
Jan 1, 2022
20.44 B TWD
Jan 1, 2023
20.40 B TWD
Jan 1, 2024
21.19 B TWD
Jan 1, 2025
21.19 B TWD
The Sunmax Biotechnology Co Enterprise Value history
YEAREnterprise ValueYoY
21.19 BTWD0.00%
21.19 BTWD+3.86%
20.40 BTWD-0.20%
20.44 BTWD-0.85%
20.62 BTWD+1.00%
20.41 BTWD-3.68%
21.19 BTWD-0.10%
21.21 BTWD+0.01%
21.21 BTWD+0.11%
21.19 BTWD+0.01%
21.19 BTWD+2.46%
20.68 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunmax Biotechnology Co Stock analysis

What does Sunmax Biotechnology Co do? SunMax Biotechnology Co., Ltd. generates revenue through the development, manufacturing, and commercialization of medical devices, biomedical materials, and bio surgical products. Its major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, and medical collagen application equipment. These products are sold to customers in the medical and beauty care industries across Taiwan, Mainland China, and other regions. The company's distribution focuses on these key markets, leveraging its product portfolio for healthcare and aesthetic applications. The firm's product line targets both medical and beauty care sectors, with collagen-based solutions serving as core offerings. Medical collagen application equipment supports clinical procedures, while collagen implants and hemostat products address surgical and wound care needs. The company's presence in Taiwan, Mainland China, and other regions enables it to serve diverse healthcare markets with standardized product offerings. SunMax Biotechnology's revenue streams are derived from the sale of collagen-based medical devices and equipment, with a focus on applications in surgery, wound care, and aesthetic treatments. By distributing its products through established channels in Taiwan, Mainland China, and other regions, the company capitalizes on demand for biocompatible materials in healthcare and beauty care industries. Sunmax Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunmax Biotechnology Co stock

Enterprise Value (EV) of Sunmax Biotechnology Co is 21.19 B TWD in 2025.

Enterprise Value (EV) of Sunmax Biotechnology Co changed from 21.19 B TWD to 21.19 B TWD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Sunmax Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Sunmax Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Sunmax Biotechnology Co

All Key Metrics — Sunmax Biotechnology Co